![David Guyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Guyer
Directeur Général chez
Eyebiotech Ltd.
Profil
David R.
Guyer was the founder of Oldtech, Inc. (founded in 2000), where the title held was Chief Executive Officer & Director.
Dr. Guyer was the founder of IVERIC bio, Inc. (founded in 2007), holding the title of Executive Chairman from 2017 to 2021.
Dr. Guyer was the founder of Imagen Biotech, Inc. (founded in 2011), serving as Executive Chairman from 2011 to 2012.
Dr. Guyer is the founder of Eyebiotech Ltd. (founded in 2021), holding the titles of President & Chief Executive Officer.
Current jobs include Chairman at Danube Pharmaceuticals, Inc.; Chairman at Visus Therapeutics, Inc. since 2021; Chairman at Tenpoint Therapeutics Ltd. since 2023; Director at Lux Biosciences, Inc. since 2006; Director at Sound Pharmaceuticals, Inc.; Director at Mimetogen Pharmaceuticals, Inc.; Director at PanOptica, Inc. since 2013; Director at iSTAR Medical SA; Director at Invectys, Inc.; and Venture Partner at SV Health Investors LLP since 2001.
Former jobs include Chairman-Ophthalmology Department & Professor at New York University School of Medicine; Director at NeoVista, Inc.; Director at Link Medicine Corp.; Director at Neurotech Pharmaceuticals, Inc. (United States); Non-Executive Director at Optos Plc in 2009; Independent Director at Beacon Therapeutics (USA), Inc. from 2014 to 2017; Independent Non-Executive Director at Oxurion NV from 2013 to 2023; Director at AlloCure, Inc.; Director at Carter BloodCare; Independent Director at EyePoint Plc from 2019 to 2024; Executive Vice President at OSI Pharmaceuticals, Inc.; and Venture Partner at SV Health Investors LLC.
Education includes a doctorate from The Johns Hopkins University School of Medicine and an undergraduate degree from Yale College.
Postes actifs de David Guyer
| Sociétés | Poste | Début |
|---|---|---|
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat ophthalmic diseases | Directeur/Membre du Conseil | 07/08/2006 |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides bio pharmaceutical services | Président | - |
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology drugs for treatment of eye diseases | Directeur/Membre du Conseil | - |
iSTAR Medical SA
 iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions | Directeur/Membre du Conseil | - |
Sound Pharmaceuticals, Inc.
 Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs that prevent and treat hearing loss | Directeur/Membre du Conseil | - |
Invectys, Inc.
 Invectys, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in development of immunotherapy approaches to treat cancer | Directeur/Membre du Conseil | - |
Visus Therapeutics, Inc.
 Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops ophthalmic therapeutic medicines | Président | 03/11/2021 |
Eyebiotech Ltd.
 Eyebiotech Ltd. BiotechnologyHealth Technology Operates as a clinical stage ophthalmology company which treats patients with sight threatening diseases | Directeur Général | 09/07/2021 |
Mimetogen Pharmaceuticals, Inc.
 Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de David Guyer
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de David Guyer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
28
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 28 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
NeoVista, Inc.
 NeoVista, Inc. Medical SpecialtiesHealth Technology Develops a device-based therapy for age-related macular degeneration | Health Technology |
Link Medicine Corp.
 Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Develops disease modifying neurodegenerative therapies | Health Technology |
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat ophthalmic diseases | Health Technology |
Sound Pharmaceuticals, Inc.
Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs that prevent and treat hearing loss | Health Technology |
Danube Pharmaceuticals, Inc.
Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides bio pharmaceutical services | Health Technology |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Health Technology |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is an active manager. | Finance |
Optos Plc
 Optos Plc Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets retinal imaging devices | Health Technology |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
Oxurion NV
 Oxurion NV Pharmaceuticals: MajorHealth Technology Develops innovative vascular biopharmaceuticals for the treatment of eye disease, vascular disease and cancer | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology Develops cell therapies for the treatment of kidney diseases, organ transplants and multi-organ injuries | Health Technology |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer | Health Technology |
Carter BloodCare
 Carter BloodCare Miscellaneous Commercial ServicesCommercial Services Provides blood components and transfusion services | Commercial Services |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology drugs for treatment of eye diseases | Health Technology |
Imagen Biotech, Inc.
 Imagen Biotech, Inc. BiotechnologyHealth Technology Develops therapeutics for blinding diseases | Health Technology |
iSTAR Medical SA
iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale College
 Yale College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Visus Therapeutics, Inc.
Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops ophthalmic therapeutic medicines | Health Technology |
Invectys, Inc.
Invectys, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in development of immunotherapy approaches to treat cancer | Health Technology |
Tenpoint Therapeutics Ltd.
 Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company developing treatments to rejuvenate vision in the aging eye | Health Technology |
Eyebiotech Ltd.
Eyebiotech Ltd. BiotechnologyHealth Technology Operates as a clinical stage ophthalmology company which treats patients with sight threatening diseases | Health Technology |
